Female Powerbrokers Q&A: Wolf Greenfield's Helen Lockhart

Law360, New York (March 18, 2014, 2:46 PM EDT) -- Helen Lockhart is a shareholder in Wolf Greenfield & Sacks PC's Boston office. Her practice involves strategic counseling on development and management of domestic and international intellectual property rights for a variety of clients, including universities, smaller and mid-sized companies, startups, and entrepreneurs.

She has broad experience in prosecuting biotechnology patents relating to immune response modulators, drug delivery, catalytic molecules, antibodies, fluorescence based micro- and nano-analysis, cell culture, mass spectrometry, nucleic acid sequencing, polymer-based and biological-based drug delivery systems, antisense nucleic acid therapeutics, peptides, small molecule...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.